Adjunctive Fosfomycin for the Treatment of <i>Staphylococcus aureus</i> Bacteremia: A Pooled Post Hoc Analysis of Individual Participant Data From 2 Randomized Trials
Adjunctive fosfomycin may improve early bacterial clearance and treatment success in SAB but at the cost of increased toxicity. Clinical Trials Registration. NCT06695832.
Authors
- Sean Wei Xiang Ong (ORCID: https://orcid.org/0000-0002-8570-436X)
- S. Tong (ORCID: https://orcid.org/0000-0001-9593-1868)
- Isabel Oriol (ORCID: https://orcid.org/0000-0001-5542-7878)
- Jordi Carratalà (ORCID: https://orcid.org/0000-0003-3209-2563)
- Sara Grillo (ORCID: https://orcid.org/0000-0002-3596-8690)
- Francesc Escrihuela-Vidal (ORCID: https://orcid.org/0000-0003-3652-3121)
- Miquel Pujol (ORCID: https://orcid.org/0000-0002-6475-6208)
- Natàlia Pallarés (ORCID: https://orcid.org/0000-0002-1462-379X)
- Kuan Liu (ORCID: https://orcid.org/0000-0002-5017-1276)
- José M. Miró
- Cristian Tebé
Institutions
- Universitat Autònoma de Barcelona (ES)
- Real Academia Española (ES)
- The Royal Melbourne Hospital (AU)
- Sunnybrook Health Science Centre (CA)
- The University of Melbourne (AU)
- University of Toronto (CA)
- Instituto de Salud Carlos III (ES)
- Hospital de Sant Pau (ES)
- Bellvitge University Hospital (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Peter Doherty Institute (AU)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Clínic de Barcelona (ES)
- Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Sunnybrook Hospital (CA)
- Sunnybrook Research Institute
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1093/cid/ciaf387
- Citations
- 2
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Pfizer
- AstraZeneca
- Gilead Sciences
- ViiV Healthcare
- Genentech
- Medical Research Council
- National Health and Medical Research Council
- Instituto de Salud Carlos III